PERCEPTIVE ADVISORS LLC
Top Portfolio Positions
95 positions ·
$4,801,404,551 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
|
1,995,986 | $588,296,913 | 12.25% |
| CELC |
Celcuity Inc.
|
3,160,200 | $315,198,348 | 6.56% |
| RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,546,391 | $272,565,692 | 5.68% |
| ASND |
Ascendis Pharma A/S
|
1,081,421 | $230,602,214 | 4.80% |
| APGE |
Apogee Therapeutics, Inc.
|
2,330,651 | $175,917,537 | 3.66% |
| ROIV |
Roivant Sciences Ltd.
|
7,985,461 | $173,284,503 | 3.61% |
| NUVL |
Nuvalent, Inc.
|
1,665,105 | $167,492,911 | 3.49% |
| TVTX |
Travere Therapeutics, Inc.
|
4,278,180 | $163,469,257 | 3.40% |
| EXAS |
EXACT SCIENCES CORP
|
1,200,487 | $121,921,459 | 2.54% |
| PTGX |
Protagonist Therapeutics, Inc
|
1,350,425 | $117,946,119 | 2.46% |
Portfolio Trend
Holdings in GOSS
Export CSVShares Held
Position Value (USD)
2 of 2 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $9,732,973 | 3,139,669 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,027,656 | 3,812,797 | Shares | Sole | 2025-11-14 | |
| No quarters match your search. | ||||||